Please ensure Javascript is enabled for purposes of website accessibility

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

3 hours ago

Will Valadao Spoil Trump’s Plan for July 4th ‘Big Beautiful Bill’ Signing?

4 hours ago

Shaver Lake and Reedley 4th of July Shows Are Wednesday. Who Else Is Celebrating?

8 hours ago

Elon Musk Says Senate Bill Would Destroy Jobs and Harm US

8 hours ago

Israel Strikes Pound Gaza, Killing 60, Ahead of US Talks on Ceasefire

9 hours ago

Trump’s Administration Finds Harvard Violated Students’ Civil Rights, WSJ Reports

9 hours ago

How Did the Supreme Court Rule? Here’s a Look at the Big Cases

2 days ago
Everything You Need to Know About Creating a Coronavirus Vaccine Fast
The-Conversation
By The Conversation
Published 5 years ago on
March 28, 2020

Share

The coronavirus has ground social, economic and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of the virus, but in the long term, a COVID-19 vaccine is the best hope of a return to normalcy.

Analysis

Jean Peccoud
The Conversation

It normally takes a few years to development a vaccine, but in the face of the coronavirus, biotechnology companies and regulatory agencies are taking aggressive steps to make a COVID-19 vaccine widely available sooner than that.
I study biomanufacturing and synthetic biology, and it is fascinating to watch this unprecedented effort push at the limits of vaccine development. Public and private labs around the world are pursuing cutting-edge vaccine engineering strategies that have never been tested on such a large scale. If these efforts succeed, the vaccine would become an essential tool to fight or prevent future COVID epidemics.

How Vaccines Work

The first time the body is exposed to a new virus, it takes weeks to build antibodies and other defense mechanisms that will fight it off. This gives the virus plenty of time to replicate and make someone sick.
However, the immune system has memory. If it has encountered a virus before, the body can quickly deploy its defenses against the invader and neutralize the virus before a full infection develops.
This is the idea behind vaccines: give the body an opportunity to build defenses against a virus it may encounter in the future. Not all vaccines produce the same level of immunological preparedness – the stronger the initial immune response, the better the vaccine – but some preparation is better than none.

Vaccines have been around for nearly 150 years, and until recently, the science hasn’t fundamentally changed. (AP File)
The traditional way of developing a vaccine is to grow and inject patients with inactivated viruses. These don’t make you sick, but once exposed to these “dead” viruses, the immune system will have the weapons to fight off that virus in the future, if it needs to.
Unfortunately, figuring out how to grow a new virus on an industrial scale is complicated, and once done, the process itself is often slow, difficult and potentially risky. For example, the flu vaccine is produced by growing the virus in millions of chicken eggs. The process takes four months. In addition, when dealing with a virus for which there is no drug or vaccine, it is safer to avoid growing it in large quantities for fear that it might accidentally leak out of the factory and make the situation even worse than it already is.
With the coronavirus literally making time a matter of life and death, nearly 50 public and private labs are turning to newer, safer and faster methods to develop a coronavirus vaccine.

Protein-Based Vaccines

Rather than injecting the whole virus, it is possible to vaccinate a person with a single virus component. The pieces most commonly used are proteins from the surface of a virus. If a live virus enters the body, these surface proteins are easily recognized by the immune system. This approach is easier, faster and safer because the virus protein can be produced in cell cultures.


Two companies, Sanofi and Novawax, are both developing protein vaccines based on the SARS-CoV-2 spike protein, the tower-shaped structures on the surface of the new coronavirus that causes COVID-19.
Protein-based vaccines, also known as recombinant vaccines, are already used to vaccinate against viral infections like HPV. They are far simpler to produce compared to traditional whole-virus vaccines, but it can still take a year to develop a new process and several weeks to produce the vaccine after the manufacturing process has been developed. The world needs something faster.

Gene-Based Vaccines

Theoretically, the simplest and fastest way to make a vaccine would be to have a person’s own cells produce minute quantities of the viral protein that trigger an immune response. To do that researchers are turning to genetics.
The first genetic approach uses DNA. A single gene that codes for a protein from the coronavirus is injected into the patient’s cells in the hopes that a small fraction of the DNA molecules will find their way into the cell nucleus. There they would be copied into an RNA molecule which is then read by the cell to produce the viral protein. But it is difficult to get the human body to produce enough protein using this approach. Frequently, very little DNA makes it to the cell nucleus and the cell does not produce the protein in sufficient quantity to trigger a strong enough immune response.
As of yet, there are no DNA vaccines currently approved by the FDA for human use and the success of this method has been limited. But there is promise. In 2016, several groups developed candidate Zika vaccines using this technology and at least one company, INOVIO Pharmaceuticals, Inc. is developing INO-4800, a DNA vaccine candidate for the coronavirus.
The bottleneck of DNA vaccines is getting the DNA to the nucleus to be transcribed into RNA. Vaccines that use RNA directly might be able to overcome this problem. Since RNA is translated into proteins as soon as it enters the cell, this approach results in stronger immune responses than DNA vaccines. However, RNA breaks down faster than DNA.
This has not deterred a number of companies from trying it though. Notable in the U.S. is Moderna, and on March 16, the National Institutes of Health started a clinical trial of Moderna’s lead coronavirus vaccine candidate, mRNA-1273.

A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)
Manufacturing DNA and RNA relies on standardized and fairly simple processes. DNA vaccines are produced in bacteria that grow overnight while RNA vaccines are produced in test tubes using a biochemical reaction that only takes hours. Gene-based vaccines could be produced extremely quickly compared to traditional or protein-based vaccines.

Friendly Virus Vaccines

The main issue with gene-based vaccines is getting the DNA or RNA to where it needs to be. One elegant way to solve this challenge is to use a harmless virus as a delivery system. Viruses are extremely good at penetrating cells; once inside, a virus with genes from SARS-CoV-2 could use the machinery of the cell to produce proteins to trigger an immune response for the coronavirus.
This technique is being pursued by a few companies around the world. For example, Hong Kong-based CanSino Biologics is inserting the coronavirus gene that codes for the spike protein into an adenovirus. They used this strategy to produce the first government-approved Ebola vaccine, and clinical trials of an engineered adenovirus that would protect against the coronavirus have already started in China.
The production of vaccines delivered by harmless viruses is slower than producing DNA or RNA vaccines because it involves the culture of slow-growing mammal cells. However, like the production of gene-based vaccines, they rely on existing processes that take advantage of viruses that have been optimized for manufacturing.

Containing the Epidemic With Imperfect Vaccines

While the pace of COVID-19 vaccine development is unprecedented, the timeline to mass vaccination still remains uncertain. While the large number of approaches being pursued may give the impression of desperation and confusion, it is actually reassuring. This multipronged approach is a way to hedge the vaccine development bet.
It is unlikely the first vaccines developed will be 100% effective and easy to produce on a massive scale. Realistically, researchers will develop a number of good-enough vaccines that can be produced using different kinds of manufacturing infrastructures. While these vaccines may at first have a limited efficacy, the diversity in manufacturing processes will allow companies to make and distribute them quickly, buying time and helping contain the current epidemic and prevent future outbreaks.
Jean Peccoud, Professor, Abell Chair in Synthetic Biology, Colorado State UniversityThis article is republished from The Conversation under a Creative Commons license. Read the original article.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Fresno Woman Killed in Head-On Collision, CHP Investigating

DON'T MISS

Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill

DON'T MISS

Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud

DON'T MISS

Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports

DON'T MISS

Wildfire Near Lake Madera Country Estates Burns 12 Acres, Now 100% Contained

DON'T MISS

Fresno County CHP Arrest Two in Interstate 5 Drug, Gun, and Counterfeit Money Bust

DON'T MISS

California Seizes Over 600,000 Pounds of Illegal Fireworks. Newsom Calls for Safe Celebrations

DON'T MISS

Where Trade Talks Stand With Major US Partners Ahead of Tariffs-Hike Deadline

DON'T MISS

Labor Icon Huerta Breaks Ground on Fresno Park Bearing Her Name

DON'T MISS

DOJ Announces Arrest, Indictments in North Korean IT Worker Scheme

UP NEXT

US Supreme Court Preserves Key Element of Obamacare

UP NEXT

US Supreme Court Backs South Carolina Effort to Defund Planned Parenthood

UP NEXT

West Nile Virus Detected in Mosquitoes in Fresno County

UP NEXT

St. Agnes’ New Chief Medical Officer Is a Kidney Care Expert

UP NEXT

US Health Secretary Kennedy Says He Brought Back 722 CDC Employees, 220 at NIH

UP NEXT

Marijuana’s Links to Heart Attack and Stroke Are Becoming Clearer

UP NEXT

‘Little Lobbyists’ Urge Senators to Oppose Trump’s Bill Cutting Medicaid

UP NEXT

US FDA Approves Gilead’s Twice-Yearly Injection for HIV Prevention

UP NEXT

Wired Wednesday: Physician Alleges Improper Inmate Care at Fresno County Jail

UP NEXT

US to Drop Guidance to Limit Alcohol to One or Two Drinks per Day, Sources Say

Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports

1 hour ago

Wildfire Near Lake Madera Country Estates Burns 12 Acres, Now 100% Contained

2 hours ago

Fresno County CHP Arrest Two in Interstate 5 Drug, Gun, and Counterfeit Money Bust

2 hours ago

California Seizes Over 600,000 Pounds of Illegal Fireworks. Newsom Calls for Safe Celebrations

2 hours ago

Where Trade Talks Stand With Major US Partners Ahead of Tariffs-Hike Deadline

2 hours ago

Labor Icon Huerta Breaks Ground on Fresno Park Bearing Her Name

2 hours ago

DOJ Announces Arrest, Indictments in North Korean IT Worker Scheme

2 hours ago

Fresno Man Arrested in Clovis for Sex-Related Crimes Against Minor

3 hours ago

Dyer’s Lobbying Works. Fresno Gets $100M for Downtown From State

3 hours ago

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

3 hours ago

Fresno Woman Killed in Head-On Collision, CHP Investigating

An 86-year-old Fresno woman was killed Monday in a head-on collision in southeast Fresno County, according to the California Highway Patrol....

26 minutes ago

fresno
26 minutes ago

Fresno Woman Killed in Head-On Collision, CHP Investigating

President Donald Trump and Elon Musk attend a press conference in the Oval Office of the White House in Washington, D.C., U.S., May 30, 2025. (Reuters File)
1 hour ago

Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill

1 hour ago

Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud

Bryan Koberger, who is accused of killing four University of Idaho students, listens during a hearing to overturn his grand jury indictment in Moscow, Idaho, U.S., October 26, 2023. (Reuters File)
1 hour ago

Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports

The Blanca Fire, burning 12 acres northwest of Lake Madera Country Estates in Madera County, remains active with 0% containment and no reported injuries or structural damage as the cause is under investigation as of Monday, June 30, 2025. (CalFire)
2 hours ago

Wildfire Near Lake Madera Country Estates Burns 12 Acres, Now 100% Contained

Fresno County CHP arrested two on Interstate 5 after finding about one kilogram of suspected cocaine, a loaded ghost gun, and counterfeit money during a vehicle search on Sunday, June 29, 2025. (CHP)
2 hours ago

Fresno County CHP Arrest Two in Interstate 5 Drug, Gun, and Counterfeit Money Bust

Gov. Newsom warns Californians to celebrate the Fourth of July safely, emphasizing zero tolerance for illegal fireworks which have surged to over 600,000 pounds seized this year. (Shutterstock)
2 hours ago

California Seizes Over 600,000 Pounds of Illegal Fireworks. Newsom Calls for Safe Celebrations

President Donald Trump delivers remarks on tariffs in the Rose Garden at the White House in Washington, D.C., U.S., April 2, 2025. (Reuters File)
2 hours ago

Where Trade Talks Stand With Major US Partners Ahead of Tariffs-Hike Deadline

Help continue the work that gets you the news that matters most.

Search

Send this to a friend